3.2 Legal Reasoning
A. Reframing “passive euthanasia” as “withdrawal/withholding of medical treatment”
The Court adopts a terminological clarification: “Euthanasia” is reserved for active euthanasia (impermissible absent legislation),
while “passive euthanasia” is treated as an obsolete/confusing label and replaced with “withdrawing or withholding of medical treatment.”
Substantively, this is not a change in law; it is a clarity move to reduce misclassification risks for clinicians.
B. CANH as “medical treatment” (including in home settings)
The Court’s key doctrinal holding is that CANH is not “basic care” but a technologically mediated clinical intervention:
it requires medical indication, device placement (including surgical PEG), prescribed formulations and rates, monitoring, complication-management
(aspiration, peritonitis, infection), and periodic review. Relying on Airdale NHS Trust v. Bland and
Re BWV; Ex parte Gardner, the Court holds that even if routine administration occurs at home, it remains medical treatment because
the regime is governed by medical protocols and supervision.
Why this matters: Under Common Cause 2018, only “medical treatment” can be lawfully withdrawn/withheld under the
passive-euthanasia framework. Declaring CANH as treatment removes a major implementation obstacle and corrects the High Court’s misapprehension that
absence of a ventilator equals absence of “life support.”
C. “Best interests of the patient”: content, method, and the “right question”
The Court places “best interests” at the centre for incompetent patients, synthesising Indian constitutional values (dignity, bodily integrity)
with comparative method. It emphasises:
- The “right question”: not whether it is in the patient’s best interests to die, but whether it is in the patient’s best interests that life be prolonged by the continuation of the treatment (echoing Lord Goff in Airdale NHS Trust v. Bland).
- Holism: best interests is not a single rigid test; it includes medical, social, psychological, and welfare considerations (drawing from Re A (Male Sterilisation), Re S (Adult Patient: Sterilisation), Portsmouth NHS Trust v Wyatt, and Aintree University Hospitals NHS Foundation Trust v James).
- Presumption for life: anchored in sanctity of life but defeasible where treatment is futile, overly burdensome, or dignity-eroding.
- Substituted judgment as a strong element, not an override: the patient’s ascertainable wishes/values should inform the inquiry, but finality rests with best interests.
- Balance-sheet methodology: once relevant factors are identified, they must be weighed—benefits vs burdens—rather than assumed.
A significant doctrinal nuance is the Court’s insistence that substituted judgment in India should be read primarily through the lens of
dignity and bodily integrity (not merely privacy/autonomy), ensuring that incompetent patients are not excluded from Article 21
protection merely because they cannot exercise choice contemporaneously.
D. Authorised omission and doctors’ duty of care
The Court reinforces that withdrawal/withholding, when done under Common Cause safeguards and in best interests,
is an “authorised omission” and not an illegal omission. The duty of care does not require futile perpetuation of biological existence; it
reorients from cure to palliation. This directly addresses clinicians’ fear of criminal liability and is intended to reduce defensive medicine.
E. Procedural operationalisation: bridging home-care gaps and administrative delays
The case exposed a real-world gap: Common Cause assumes a hospital setting that can constitute boards, but many PVS patients are managed
at home. The Court clarifies that families may (i) admit the patient to a hospital of choice to trigger the process, or (ii) seek designation of a
primary treating physician to initiate the protocol. Further, to reduce delays in constitution of Secondary Boards, the Court mandates that CMOs maintain
an updated panel of eligible registered medical practitioners for nomination.
F. Implementation must be palliative, not abandonment
A critical normative development is the Court’s insistence that withdrawal is not a single abrupt act and must not translate into abandonment:
it must be implemented through a structured palliative/EOL care plan. The Court’s strong disapproval of “discharge against medical advice” practices
signals that “treatment limitation” cannot become “care cessation.”